# Chemotherapy Regime Therapy Naming Conventions

Chemotherapy regimens, which are internationally recognized and implemented, are acceptable content and may be added to the (regime/therapy) hierarchy as subtypes of [ 716872004 | Antineoplastic chemotherapy regimen (regime/therapy)|](http://snomed.info/id/716872004 "716872004 | Antineoplastic chemotherapy regimen \(regime/therapy\) |") .

Trade names, which are indicated by an acronym, e.g. ABVD chemotherapy regimen, where _A_ represents trade name Adriamycin®, should not be spelled out but may be referenced in the acronym used to describe the regimen.

Generic drug names are not capitalized; they are lower case. When creating descriptions for generic drug names, the substance described should match the description from the Substance hierarchy.

  

#### Examples, 

**ABVD chemotherapy regimen.** _A_ represents the trade name Adriamycin® (INN = doxorubicin):

  *     * FSN: Doxorubicin, bleomycin, vinblastine and dacarbazine chemotherapy regimen (regime/therapy)
    * PT: ABVD chemotherapy regimen
    * Synonym: Doxorubicin, bleomycin, vinblastine and dacarbazine chemotherapy regimen
    * Synonym: ABVD chemotherapy protocol

**R-CHOP chemotherapy regimen.**_H_ represents the non-INN generic name hydroxydaunomycin (INN = doxorubicin) and _O_ represents the trade name Oncovin® (INN = vincristine):

  *     * FSN: Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy regimen (regime/therapy)
    * PT: R-CHOP chemotherapy regimen
    * Synonym: Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy regimen
    * Synonym: R-CHOP chemotherapy protocol

